Home Cart Sign in  
Chemical Structure| 361442-04-8 Chemical Structure| 361442-04-8

Structure of Saxagliptin
CAS No.: 361442-04-8

Chemical Structure| 361442-04-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Saxagliptin is a selective and reversible DPP4 inhibitor with IC50 of 26 nM.

Synonyms: BMS-477118

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Saxagliptin

CAS No. :361442-04-8
Formula : C18H25N3O2
M.W : 315.41
SMILES Code : N#C[C@H]1N(C([C@@H](N)C23CC4(O)CC(C3)CC(C4)C2)=O)[C@@]5([H])C[C@@]5([H])C1
Synonyms :
BMS-477118
MDL No. :MFCD12756398

Safety of Saxagliptin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01646320 - Completed - -
NCT02377388 Platelet Aggregation During Ac... More >>ute Myocardial Infarction Less << Phase 3 Recruiting December 2019 Brazil ... More >> Heart Institute(InCor)-Acute Coronary Care Unit Recruiting São Paulo, SP, Brazil, 01406000 Contact: Paulo R Genestreti, MD    55 11 2661-5058    paulo.gen@ig.com.br    Principal Investigator: Jose C Nicolau, MD,PhD          Sub-Investigator: Paulo R Genestreti, MD Less <<
NCT01646320 Type 2 Diabetes Phase 3 Completed - -
NCT01782261 Type 1 Diabetes Phase 2 Completed - Austria ... More >> Medical University Graz Graz, Austria, 8036 Less <<
NCT02583438 Type 2 Diabetes ... More >> Obesity Less << Phase 4 Unknown January 2018 -
NCT02223065 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT02223065 - Completed - -
NCT02239458 Cystic Fibrosis UNKNOWN 2025-06-16 Hadassah Ein Kerem/Har Hazofim... More >>, Jerusalem, 91120, Israel Less <<
NCT02742233 Diabetic Foot Ulcer Phase 4 Recruiting November 2017 China, Chongqing ... More >> The Second Affiliated Hospital, Third Military Medical University Recruiting Chongqing, Chongqing, China, 400037 Principal Investigator: Hongting Zheng, Ph.D Less <<
NCT01582308 - Completed - -
NCT00316082 Diabetes Phase 3 Completed - -
NCT02148978 Cystic Fibrosis UNKNOWN - Hadassah Har Hazofim, Jerusale... More >>m, Israel Less <<
NCT00316082 - Completed - -
NCT01582308 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT02588859 - Completed - India ... More >> Research Site Nellure, Andhra Pradesh, India Research Site Vishakhapatnam, Andhra Pradesh, India Research Site Guwahati, Assam, India Research Site New Delhi, Delhi, India Research Site Ahmedabad, Gujarat, India Research Site Rajkot, Gujarat, India Research Site Vadodara, Gujarat, India Research Site Karnal, Haryana, India Research Site Yamunanagar, Haryana, India Research Site Bangalore, Karnataka, India Research Site Trivandrum, Kerala, India Research Site Cochin, Kochi, India Research Site Bhopal, Madhya Pradesh, India Research Site Indore, Madhya Pradesh, India Research Site Mumbai, Maharashtra, India Research Site Pune, Maharashtra, India Research Site Amritsar, Punjab, India Research Site Chandigarh, Punjab, India Research Site Ludhiana, Punjab, India Research Site Jaipur, Rajasthan, India Research Site Udaipur, Rajasthan, India Research Site Madurai, Tamiladu, India Research Site Chennai, Tamilnadu, India Research Site Hyderabad, Telangana, India Research Site Hyderebad, Telangana, India Research Site Allahabad, Uttar Pradesh, India Research Site Kanpur, Uttar Pradesh, India Research Site Lucknow, Uttar Pradesh, India Research Site Noida, Uttar Pradesh, India Research Site Kolkata, West Bengal, India Research Site new Delhi, India Less <<
NCT00121667 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00950599 - Completed - -
NCT02284893 Type 2 Diabetes Phase 3 Completed - -
NCT00121667 - Completed - -
NCT02284893 - Completed - -
NCT01525225 - Terminated(Release of Post Mar... More >>keting Requirement for this study. Terminated November 2013.) Less << - -
NCT01525225 Type 2 Diabetes Mellitus Phase 1 Terminated(Release of Post Mar... More >>keting Requirement for this study. Terminated November 2013.) Less << - United States, Arkansas ... More >> Osborne Research Center Little Rock, Arkansas, United States, 72201 United States, California Axis Clinical Trials Los Angeles, California, United States, 90036 United States, Kentucky Kosair Charities Pediatric Clinical Research Unit Louisville, Kentucky, United States, 40202 United States, Missouri The Children'S Mercy Hospital And Clinics Kansas City, Missouri, United States, 64108 United States, Ohio Promedica Toledo Children'S Hospital Toledo, Ohio, United States, 43606 Promedica Toledo Childrens Hospital Toledo, Ohio, United States, 43606 United States, Pennsylvania Childrens Hospital Of Pittsburgh Of Upmc Pittsburgh, Pennsylvania, United States, 15224 Less <<
NCT01874080 Diabetes Phase 1 Completed - United States, Texas ... More >> Icon Development Solutions San Antonio, Texas, United States, 78209 Less <<
NCT03169959 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Maryland ... More >> Research Site Baltimore, Maryland, United States, 21225 Less <<
NCT02613897 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Texas ... More >> The University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT01162876 Diabetes Phase 3 Completed - Japan ... More >> Kyushu Clinical Pharmacology Reserch Clinic Fukuoka, Japan Less <<
NCT01606007 Type 2 Diabetes Phase 3 Completed - -
NCT01606007 - Completed - -
NCT00121641 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00313313 Diabetes Phase 3 Completed - -
NCT00313313 - Completed - -
NCT00374907 Type 2 Diabetes Phase 3 Completed - United States, California ... More >> Va San Diego Healthcare System San Diego, California, United States, 92161 United States, Louisiana Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 United States, Texas Diabetes & Glandular Disease Research Assoc,, Inc. San Antonio, Texas, United States, 78229 Less <<
NCT02060201 Type 2 Diabetes Mellitus Phase 1 Completed - -
NCT00374907 - Completed - -
NCT02920801 Type 2 Diabetes Mellitus Phase 4 Completed - China, Shanghai ... More >> Fang Li Shanghai, Shanghai, China, 200032 Less <<
NCT00950599 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT00295633 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00295633 - Completed - -
NCT00327015 Diabetes Phase 3 Completed - -
NCT01365091 Type 2 Diabetes Mellitus Phase 1 Completed - Brazil ... More >> Local Institution Campinas, Sao Paulo, Brazil, 13073 Less <<
NCT01768208 Type 2 Diabetes PHASE4 UNKNOWN 2025-12-17 Shanghai Jiao Tong University ... More >>School of Medicine, Shanghai, Shanghai, 200025, China Less <<
NCT03608358 Type 2 Diabetes Mellitus Phase 3 Not yet recruiting March 1, 2021 China ... More >> Research Site Not yet recruiting Baotou, China, 014016 Research Site Not yet recruiting Beijing, China, 100039 Research Site Not yet recruiting Beijing, China, 100044 Research Site Not yet recruiting Beijing, China, 100101 Research Site Not yet recruiting Beijing, China, 100144 Research Site Not yet recruiting Beijing, China, 101199 Research Site Not yet recruiting Beijing, China, 101200 Research Site Not yet recruiting Changchun, China, 130021 Research Site Not yet recruiting Chenzhou, China Research Site Withdrawn Chongqing, China, 400014 Research Site Not yet recruiting Fuzhou, China, 350025 Research Site Withdrawn Guangzhou, China, 510000 Research Site Withdrawn Guangzhou, China, 510080 Research Site Not yet recruiting Guangzhou, China, 510515 Research Site Not yet recruiting Haerbin, China, 150001 Research Site Not yet recruiting Hefei, China, 230001 Research Site Not yet recruiting Hefei, China Research Site Not yet recruiting Hengyang, China, CN-421001 Research Site Not yet recruiting Hohhot, China, 010017 Research Site Not yet recruiting Huizhou, China, 516001 Research Site Not yet recruiting Jinan, China, 250001 Research Site Withdrawn Jinzhou, China, 121004 Research Site Withdrawn Nanchang, China, 330006 Research Site Not yet recruiting Nanjing, China, 210012 Research Site Not yet recruiting Nanjing, China, 210029 Research Site Not yet recruiting Nantong, China, 226001 Research Site Not yet recruiting Qingdao, China, 266003 Research Site Not yet recruiting Shanghai, China, 200240 Research Site Not yet recruiting Shantou, China, 515065 Research Site Not yet recruiting Shengyang, China, 110004 Research Site Not yet recruiting Tangshan, China Research Site Not yet recruiting Tianjin, China, 300211 Research Site Not yet recruiting Wuhan, China, 430033 Research Site Not yet recruiting Wuhan, China, CN-430022 Research Site Not yet recruiting Wulumuqi, China, 830054 Research Site Not yet recruiting Xian, China, 710061 Research Site Withdrawn Xining, China, 810001 Research Site Not yet recruiting Yancheng, China, 224005 Research Site Withdrawn Yinchuan, China, 750004 Research Site Not yet recruiting Yueyang, China, 414000 Research Site Not yet recruiting Zhuzhou, China, 412007 Thailand Research Site Not yet recruiting Bangkok, Thailand, 10400 Vietnam Research Site Not yet recruiting Ho Chi Minh, Vietnam, 10000 Research Site Not yet recruiting Ho Chi Minh, Vietnam Less <<
NCT00121641 - Completed - -
NCT01365091 - Completed - -
NCT01619059 Type 2 Diabetes Phase 3 Completed - -
NCT03138356 Type 2 Diabetes Mellitus Phase 1 Completed - United Kingdom ... More >> Research Site Harrow, United Kingdom, HA1 3UJ Less <<
NCT00327015 - Completed - -
NCT01223456 - Terminated(Inability to recrui... More >>t adequate number of patients within the specified time period.) Less << - Philippines ... More >> Research Site Batangas City, Batangas, Philippines Research Site Cebu City, Cebu, Philippines Research Site Davao City, Davao, Philippines Research Site Iloilo City, Iloilo, Philippines Research Site Las Pinas City, Manila, Philippines Research Site Makati, Manila, Philippines Research Site Pasig, Manila, Philippines Research Site Quezon City, Manila, Philippines Research Site Mabalacat, Pampanga, Philippines Research Site Manila, Philippines Less <<
NCT01575483 - Completed - Korea, Republic of ... More >> Research Site Seoul, Korea, Republic of Less <<
NCT00885378 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01619059 - Completed - -
NCT00661362 Type 2 Diabetes Phase 3 Completed - -
NCT00661362 - Completed - -
NCT01267448 Diabetes Mellitus Type 2 ... More >> Severe Hyperglycemia - Blood Glucose Level >300mg/dl. Less << Phase 4 Unknown December 2012 United States, Illinois ... More >> John Stroger Hospital of Cook County Not yet recruiting Chicago, Illinois, United States, 60612 Contact: Ambika Babu, M.D.    312-864-0543    Ambika_Babu@rush.edu    Contact: Leon Fogelfeld, M.D.    312-864-0539    lfogelfe@cchil.org    Principal Investigator: Ambika Babu, M.D.          John Stroger Hospital of Cook County Recruiting Chicago, Illinois, United States, 60612 Contact: Ambika Babu, M.D.    312-864-0543    aamblee@hotmail.com    Contact: Leon Fogelfeld, M.D.    312-864-0539    lfogelfe@cchil.org    Principal Investigator: Ambika Babu, M.D. Less <<
NCT00918138 Type 2 Diabetes Phase 3 Completed - United States, Arizona ... More >> Dedicated Phase I, Inc. Phoenix, Arizona, United States, 85013 United States, California Pacific Sleep Medicine Services (Avastra Clinical Trials) Redlands, California, United States, 92373 Orange County Research Center Tustin, California, United States, 92780 United States, Florida Clinical Research Of South Florida Coral Gables, Florida, United States, 33134 Palm Springs Research Institute Hialeah, Florida, United States, 33012 Healthcare Clinical Data, Inc. North Miami, Florida, United States, 33161 United States, Georgia River Birch Research Alliance, Llc Blue Ridge, Georgia, United States, 30513 United States, Michigan Jasper Clinic, Inc. Kalamazoo, Michigan, United States, 49007 United States, New York Clinilabs, Inc. New York, New York, United States, 10019 United States, Ohio Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States, 45212 United States, Texas Clinical Trials Of Texas Inc. San Antonio, Texas, United States, 78229 United States, Utah Advanced Clinical Research West Jordan, Utah, United States, 84088 Argentina Local Institution Capital Federal, Buenos Aires, Argentina, 1429 Local Institution Buenos Aires, Argentina, 1425 Israel Local Institution Beer-Sheva, Israel, 84101 Local Institution Holon, Israel, 58100 Local Institution Kfar-Saba, Israel, 44281 Local Institution Zefat, Israel, 13100 Mexico Local Institution Monterrey, Nuevo Leon, Mexico, 64460 Local Institution Durango, Mexico, 34000 Local Institution Durango, Mexico, 34075 Less <<
NCT00918138 - Completed - -
NCT01006603 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT02419612 Diabetes Phase 3 Active, not recruiting August 15, 2019 -
NCT00899470 - Completed - -
NCT02419612 - Active, not recruiting - -
NCT01204775 Type 2 Diabetes Phase 3 Completed - United States, California ... More >> Research Site Los Angeles, California, United States Research Site San Diego, California, United States United States, Florida Research Site Hollywood, Florida, United States Research Site Tallahassee, Florida, United States Research Site Tampa, Florida, United States United States, Michigan Research Site Dearborn, Michigan, United States United States, New York Research Site Buffalo, New York, United States United States, Tennessee Research Site Memphis, Tennessee, United States United States, Virginia Research Site Richmond, Virginia, United States Russian Federation Research Site Moscow, Russian Federation Research Site Novosibirsk, Russian Federation Research Site Saint Petersburg, Russian Federation South Africa Research Site Cape Town, South Africa Research Site Pretoria, South Africa Taiwan Research Site Taichung, Taiwan Research Site Taipei, Taiwan Less <<
NCT01006603 - Completed - -
NCT01608724 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << PHASE4 COMPLETED 2025-05-14 Research Site, Baotou, China|R... More >>esearch Site, Beijing, China|Research Site, Benxi, China|Research Site, Changchun, China|Research Site, Chengdu, China|Research Site, Chongqing, China|Research Site, Dalian, China|Research Site, Dongguan, China|Research Site, Foshan, China|Research Site, Fuzhou, China|Research Site, Guangzhou, China|Research Site, Guiyang, China|Research Site, Haikou, China|Research Site, Hangzhou, China|Research Site, Hhht, China|Research Site, Hubei, China|Research Site, Jimo, China|Research Site, Jinan, China|Research Site, Kunming, China|Research Site, Linyi, China|Research Site, Nanjing, China|Research Site, Nantong, China|Research Site, Qingdao, China|Research Site, Shanghai, China|Research Site, Shantou, China|Research Site, Shenyang, China|Research Site, Shiyan, China|Research Site, Suzhou, China|Research Site, Taiyuan, China|Research Site, Tianjin, China|Research Site, Urumqi, China|Research Site, Wenzhou, China|Research Site, Wuhan, China|Research Site, Wuxi, China|Research Site, Xian, China|Research Site, Zhanjiang, China|Research Site, Zhengzhou, China Less <<
NCT00885378 - Completed - -
NCT01608724 Diabetes Mellitus, Non-Insulin... More >>-Dependent Less << PHASE4 COMPLETED 2025-05-14 Research Site, Baotou, China|R... More >>esearch Site, Beijing, China|Research Site, Benxi, China|Research Site, Changchun, China|Research Site, Chengdu, China|Research Site, Chongqing, China|Research Site, Dalian, China|Research Site, Dongguan, China|Research Site, Foshan, China|Research Site, Fuzhou, China|Research Site, Guangzhou, China|Research Site, Guiyang, China|Research Site, Haikou, China|Research Site, Hangzhou, China|Research Site, Hhht, China|Research Site, Hubei, China|Research Site, Jimo, China|Research Site, Jinan, China|Research Site, Kunming, China|Research Site, Linyi, China|Research Site, Nanjing, China|Research Site, Nantong, China|Research Site, Qingdao, China|Research Site, Shanghai, China|Research Site, Shantou, China|Research Site, Shenyang, China|Research Site, Shiyan, China|Research Site, Suzhou, China|Research Site, Taiyuan, China|Research Site, Tianjin, China|Research Site, Urumqi, China|Research Site, Wenzhou, China|Research Site, Wuhan, China|Research Site, Wuxi, China|Research Site, Xian, China|Research Site, Zhanjiang, China|Research Site, Zhengzhou, China Less <<
NCT01204775 - Completed - -
NCT02551874 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02917031 Type 2 Diabetes Mellitus ... More >> Heart Failure Less << Phase 4 Recruiting November 13, 2019 -
NCT02551874 - Completed - -
NCT00897390 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Nebraska ... More >> Mds Pharma Services Lincoln, Nebraska, United States, 68502 Less <<
NCT01068717 - Completed - -
NCT00897390 - Completed - -
NCT00683657 - Completed - -
NCT01206647 Diabetes Mellitus, Type 2 Phase 4 Unknown February 2011 Germany ... More >> Diabetologische Schwerpunktpraxis Dr. Lorra / Dr. Bonnermann Bochum, Germany, 44869 Zentrum für klinische Studien Dresden, GWT-TUD GmbH Dresden, Germany, 01307 Gemeinschaftspraxis Partner der Gesundheit Essen, Germany, 45355 IKFE Institute for Clinical Research and Development Mainz, Germany, 55116 Zentrum für Diabetes und Gefäßerkrankungen Münster, Germany, 48145 Diabetes Zentrum Neuwied Neuwied, Germany, 56564 ikfe Studiencenter Potsdam GmbH Potsdam, Germany, 14469 Less <<
NCT01068717 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> Ppd Development, Lp Austin, Texas, United States, 78744 Less <<
NCT02022007 Polycystic Ovary Syndrome ... More >> Disorder of Glucose Regulation Less << Phase 3 Completed - United States, Louisiana ... More >> Woman's Hospital Baton Rouge, Louisiana, United States, 70817 Less <<
NCT02022007 - Completed - -
NCT00666458 Type 2 Diabetes Phase 3 Completed - -
NCT00683657 Type 2 Diabetes Phase 3 Completed - -
NCT01006590 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT00899470 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Nebraska ... More >> Mds Pharma Services Lincoln, Nebraska, United States, 68502 Less <<
NCT00666458 - Completed - -
NCT00960076 Type 2 Diabetes Phase 3 Completed - -
NCT01107886 Type 2 Diabetes Mellitus Phase 4 Completed - -
NCT01006590 - Completed - -
NCT00757588 Type 2 Diabetes Phase 3 Completed - -
NCT00757588 - Completed - -
NCT01434186 - Completed - -
NCT01434186 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, California ... More >> Research Site Los Angeles, California, United States United States, Florida Research Site Tallahassee, Florida, United States United States, Michigan Research Site Dearborn, Michigan, United States United States, Minnesota Research Site St. Paul, Minnesota, United States United States, New York Research Site Mineola, New York, United States United States, Ohio Research Site Cleveland, Ohio, United States United States, Tennessee Research Site Memphis, Tennessee, United States Belgium Research Site Namur, Belgium Canada, Alberta Research Site Calgary, Alberta, Canada India Research Site Bangalore, India Mexico Research Site Aguascalientes, Mexico Research Site Meridas, Mexico Research Site Monterrey, Mexico Research Site Veracruz, Mexico Taiwan Research Site Taichung, Taiwan United Kingdom Research Site Leicester, United Kingdom Less <<
NCT01128153 Type 2 Diabetes Phase 3 Completed - -
NCT01527747 Type 2 Diabetes|Hypertriglycer... More >>idemia Less << PHASE4 SUSPENDED 2025-12-24 Oregon Health & Science Univer... More >>sity, Portland, Oregon, 97239, United States Less <<
NCT00614939 Type 2 Diabetes Phase 3 Completed - -
NCT01107886 - Completed - -
NCT00698932 Type 2 Diabetes Phase 3 Completed - -
NCT00960076 - Completed - -
NCT00698932 - Completed - -
NCT00614939 - Completed - -
NCT00575588 Type 2 Diabetes Phase 3 Completed - -
NCT02471404 Type 2 Diabetes Mellitus ... More >> Inadequate Glycaemic Control Less << Phase 4 Completed - -
NCT00575588 - Completed - -
NCT01703637 Type 2 Diabetes Mellitus Not Applicable Unknown - China, Shandong ... More >> YuCheng people's hospital Recruiting Dezhou, Shandong, China, 253000 Contact: Pengfei Li       lpf9669@163.com    Hospital of SINOTRUK Recruiting Jinan, Shandong, China, 250010 Contact: Xiling Fu       fxl1936@163.com    Jinan central hospital Recruiting Jinan, Shandong, China, 250010 Contact: Shuguang Pang       shuguangpang@163.com    The jinan military region general hospital Recruiting Jinan, Shandong, China, 250010 Contact: Zhaoshun Jiang       zhaoshunjiang@sohu.com    Qianfoshan Hospital Recruiting Jinan, Shandong, China, 250012 Contact: Lin Liao, MD    8615168888260    liaolin@medmail.com.cn    People's Hospital of Qingdao Chengyang Recruiting Qingdao, Shandong, China, 266100 Contact: Xiaopang Rao       123raoxiaopang@163.com    Zibo central hospital Recruiting Zibo, Shandong, China, 255000 Contact: Xiaodong Zhao       19xiaodong@163.com    Zibo eighth people's hospital Recruiting Zibo, Shandong, China, 255000 Contact: Ling Dai    +86 13853388549 Less <<
NCT01192139 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> Ppd Development, Lp Austin, Texas, United States, 78744 Less <<
NCT01192139 - Completed - -
NCT01068743 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> PPD Development, LP Austin, Texas, United States, 78744 Less <<
NCT01192152 - Completed - -
NCT01960205 Prediabetes Phase 4 Unknown - China, Shandong ... More >> Shandong Provincial Hospital Recruiting Jinan, Shandong, China, 250021 Contact: Xinli Zhou, MD, PhD    15168889976    zhouxinli0301@163.com    Principal Investigator: Xinli Zhou, MD,PhD Less <<
NCT01128153 - Completed - -
NCT02315495 Type 2 Diabetes Phase 3 Completed - China, Jiangsu ... More >> Department of Endocrinology, Zhongda Hospital. Institute of Diabetes, Southeast University Nanjing, Jiangsu, China Less <<
NCT02481479 Diabetes Mellitus, Non-Insulin... More >>-Dependent Heart Failure Less << Phase 4 Unknown December 2017 Canada, Ontario ... More >> St Michael's Hospital Recruiting Toronto, Ontario, Canada, M5B1W8 Less <<
NCT01192152 Diabetes Mellitus Phase 1 Completed - United States, Texas ... More >> PPD Development, LP Austin, Texas, United States, 78744 Less <<
NCT01662999 - Completed - -
NCT01305551 Type 2 Diabetes Phase 1 Withdrawn - Brazil ... More >> Local Institution Campinas, Sao Paulo, Brazil, 13073 Less <<
NCT00918879 - Completed - -
NCT01068743 - Completed - -
NCT01662999 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Nebraska ... More >> Icon Clinical Pharmacology Omaha, Nebraska, United States, 68154 Less <<
NCT01319357 Diabetes Mellitus Type 2 Phase 3 Completed - Germany ... More >> Clinical Research Center, Department of Nephrology and Hypertension, University of Erlangen-Nuremberg Erlangen, Germany, 91054 Less <<
NCT01521312 Impaired Glucose Tolerance Phase 2 Completed - France ... More >> Jean Verdier hospital, Department of Endocrinology-Diabetology-Nutrition Bondy, France, 93140 Less <<
NCT00770302 Type 2 Diabetes PHASE1 COMPLETED 2025-10-08 Research Site, Beijing, China
NCT00918879 Type 2 Diabetes Phase 3 Completed - India ... More >> Research Site Gujarat, Ahmedabad, India Research Site Karnataka, Bangalore, India Research Site Tamil Nadu, Chennai, India Research Site Tamil Nadu, Coimbatore, India Research Site Andhra Pradesh, Hyderabad, India Research Site Madhya Pradesh, Indore, India Research Site Haryana, Karnal, India Research Site Kerala, Kochi, India Research Site Maharashtra, Pune, India Less <<
NCT02605772 Type 2 Diabetes Mellitus Phase 4 Unknown March 2017 -
NCT02243176 Type 2 Diabetes Mellitus Phase 4 Completed - China ... More >> Research Site Shanghai, China Less <<
NCT02304081 Type2 Diabetes Mellitus Phase 4 Completed - Germany ... More >> Profil Mainz GmbH & Co. KG Mainz, Germany, 55116 Less <<
NCT01755494 Type 2 Diabetes Mellitus(T2DM) Phase 1 Completed - China ... More >> Research Site Beijing, China Less <<
NCT02104804 Type 2 Diabetes Mellitus Phase 3 Completed - China ... More >> Research Site Beijing, China Research Site Changchun, China Research Site Fuzhou, China Research Site Guangzhou, China Research Site Ha'er bing, China Research Site Hefei, China Research Site Nanchang, China Research Site Nanjing, China Research Site Shanghai, China Research Site ShiJiazhuang, China Research Site Shiyan, China Less <<
NCT03714594 Glucose, Low Blood Phase 2 Recruiting September 2021 Italy ... More >> Department of Endocrinology and Metabolism, University of Pisa Recruiting Pisa, Italy, 56124 Contact: Stefano Del Prato, MD    +39 050 995103    stefano.delprato@med.unipi.it    Sub-Investigator: Giuseppe Daniele, MD Less <<
NCT02104804 - Completed - -
NCT02182895 Diabetes Mellitus PHASE4 COMPLETED 2025-02-17 Brigham and Women's Hospital, ... More >>Boston, Massachusetts, 02115, United States Less <<
NCT01552005 Type 2 Diabetes Mellitus (T2D) COMPLETED 2025-06-15 -
NCT01765270 Type 2 Diabetes Mellitus ... More >> Cardiovascular Disease Less << Phase 4 Terminated(The study was stopp... More >>ed due to poor enrollment.) Less << - United States, Alabama ... More >> Cardiology, PC Birmingham, Alabama, United States, 35211 Cardio-Thoracic Surgeons PC Birmingham, Alabama, United States, 35243 Heart Center Research, LLC Huntsville, Alabama, United States, 35801 United States, Arkansas Sparks Regional Medical Center Fort Smith, Arkansas, United States, 72901 Arkansas Cardiology, PA Little Rock, Arkansas, United States, 72205 United States, California Stanford University Medical Center Palo Alto, California, United States, 94304 United States, Georgia Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 United States, North Carolina Duke University Medical Center (DUMC) Durham, North Carolina, United States, 27710 United States, Virginia Chippenham Medical Center Richmond, Virginia, United States, 23225 United States, West Virginia Charleston Area Medical Center (CAMC) Charleston, West Virginia, United States, 25304 Less <<
NCT02547935 Type 2 Diabetes Mellitus, CKD ... More >>and Albuminuria Less << Phase 2 Phase 3 Completed - -
NCT02280486 Type 2 Diabetes Phase 4 Completed - China, Jiangsu ... More >> at Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University Nanjing, Jiangsu, China, 210008 Less <<
NCT01765270 - Terminated(The study was stopp... More >>ed due to poor enrollment.) Less << - -
NCT02243176 - Completed - -
NCT00935467 Type 2 Diabetes Mellitus PHASE1 COMPLETED 2025-08-09 Ppd Development, Lp, Austin, T... More >>exas, 78744, United States Less <<
NCT03660683 Diabetes Mellitus, Type 2 ... More >> Cardiovascular Diseases Less << Phase 4 Recruiting July 1, 2020 United States, District of Col... More >>umbia The GW Medical Faculty Associates Recruiting Washington, District of Columbia, United States, 20037 Contact: Hassan Awal, MD       hawal@mfa.gwu.edu Less <<
NCT01552018 Coronary Artery Disease ... More >> Diabetes Mellitus Type 2 Less << Phase 4 Completed - Norway ... More >> Center for Clinical Heart Research, Dept. of Cardiology, Oslo University Hospital Ullevaal Oslo, Norway, N-0424 Less <<
NCT01441869 Bioequivalence, Log-transforme... More >>d AUCss and Cmax,ss Values for Saxagliptin and Metformin Less << Phase 1 Completed - United States, Kansas ... More >> Research Site Overland Park, Kansas, United States Less <<
NCT01548651 Impaired Glucose Tolerance Phase 4 Terminated(difficulty with enr... More >>ollment of subjects) Less << - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT02273050 Type 2 Diabetes Mellitus Phase 3 Completed - China ... More >> Research Site Beijing, China Research Site Changchun, China Research Site Chuangchun, China Research Site Fuzhou, China Research Site Guiyang, China Research Site Ha'er bin, China Research Site Hangzhou, China Research Site Hefei, China Research Site Jinan, China Research Site Nanchang, China Research Site Nanjing, China Research Site Shanghai, China Research Site Shijiazhuang, China Research Site Siping, China Research Site Tianjin, China Research Site Wuxi, China Research Site Yueyang, China Less <<
NCT02182895 Diabetes Mellitus PHASE4 COMPLETED 2025-02-17 Brigham and Women's Hospital, ... More >>Boston, Massachusetts, 02115, United States Less <<
NCT02024477 Type 2 Diabetes Phase 4 Active, not recruiting January 2018 United States, District of Col... More >>umbia Medical Faculty Associates Inc Washington, District of Columbia, United States, 20037 Less <<
NCT02273050 - Completed - -
NCT02965443 Type 2 Diabetes Phase 4 Recruiting June 2020 Germany ... More >> University Hospital Tübingen Recruiting Tübingen, Germany, 72076 Contact: Norbert Stefan, Prof. Less <<
NCT02681094 Type 2 Diabetes Mellitus ... More >> Inadequate Glycaemic Control Less << Phase 3 Completed - -
NCT02407899 Diabetes Mellitus, Type 1 Phase 4 Recruiting June 2018 China, Hunan ... More >> Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University Recruiting Changsha, Hunan, China, 410011 Contact: Zhiguang Zhou, MD/PhD    86-731-85292154    zhouzg@hotmail.com Less <<
NCT03199053 Diabetes Mellitus, Type 2 Phase 3 Recruiting December 20, 2021 -
NCT02285985 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 4 Active, not recruiting December 2018 United States, Arizona ... More >> Carl T. Hayden VA Medical Hospital Phoenix, Arizona, United States, 85012 Less <<
NCT02681094 - Completed - -
NCT02307695 Type 1 Diabetes Phase 4 Unknown March 2017 China, Jiangsu ... More >> First Affiliated Hospital, Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210029 Contact: Tao Yang, PhD    86-25-83718836 ext 6466    yangt@njmu.edu.cn    Principal Investigator: Tao Yang, PhD Less <<
NCT02462369 Microalbuminuria ... More >> Microalbuminuria /Creatinine Ratios ACR Less << Phase 4 Unknown October 2017 -
NCT01922817 Type 1 Diabetes|Hypoglycaemia PHASE3 COMPLETED 2025-04-14 Clinical research centre, Nine... More >>wells Hospital and Medical School, Dundee, DD1 9SY, United Kingdom Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.17mL

0.63mL

0.32mL

15.85mL

3.17mL

1.59mL

31.70mL

6.34mL

3.17mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories